nodes	percent_of_prediction	percent_of_DWPC	metapath
Alvimopan—Indinavir—SLC22A1—hematologic cancer	0.00466	0.443	CrCbGaD
Alvimopan—Benazepril—MTHFR—hematologic cancer	0.00382	0.363	CrCbGaD
Alvimopan—Connective tissue disorder—Bexarotene—hematologic cancer	0.00346	0.00487	CcSEcCtD
Alvimopan—Urethral disorder—Bexarotene—hematologic cancer	0.00345	0.00486	CcSEcCtD
Alvimopan—Urethral disorder—Dasatinib—hematologic cancer	0.00345	0.00486	CcSEcCtD
Alvimopan—Anaemia—Daunorubicin—hematologic cancer	0.00345	0.00484	CcSEcCtD
Alvimopan—Anaemia—Clofarabine—hematologic cancer	0.00345	0.00484	CcSEcCtD
Alvimopan—Anaemia—Pentostatin—hematologic cancer	0.00343	0.00482	CcSEcCtD
Alvimopan—Anaemia—Anagrelide—hematologic cancer	0.00343	0.00482	CcSEcCtD
Alvimopan—Hypokalaemia—Bortezomib—hematologic cancer	0.00342	0.0048	CcSEcCtD
Alvimopan—Urinary retention—Thiotepa—hematologic cancer	0.00333	0.00468	CcSEcCtD
Alvimopan—Anaemia—Idarubicin—hematologic cancer	0.00331	0.00465	CcSEcCtD
Alvimopan—Malnutrition—Busulfan—hematologic cancer	0.00323	0.00453	CcSEcCtD
Alvimopan—Anaemia—Teniposide—hematologic cancer	0.00322	0.00452	CcSEcCtD
Alvimopan—Urinary tract disorder—Nilotinib—hematologic cancer	0.00322	0.00452	CcSEcCtD
Alvimopan—Connective tissue disorder—Nilotinib—hematologic cancer	0.0032	0.0045	CcSEcCtD
Alvimopan—Urinary tract disorder—Imatinib—hematologic cancer	0.0032	0.00449	CcSEcCtD
Alvimopan—Urethral disorder—Nilotinib—hematologic cancer	0.00319	0.00449	CcSEcCtD
Alvimopan—Connective tissue disorder—Imatinib—hematologic cancer	0.00318	0.00447	CcSEcCtD
Alvimopan—Urethral disorder—Imatinib—hematologic cancer	0.00317	0.00446	CcSEcCtD
Alvimopan—Urinary tract disorder—Cladribine—hematologic cancer	0.00314	0.00442	CcSEcCtD
Alvimopan—Connective tissue disorder—Cladribine—hematologic cancer	0.00313	0.00439	CcSEcCtD
Alvimopan—Back pain—Busulfan—hematologic cancer	0.00312	0.00439	CcSEcCtD
Alvimopan—Urethral disorder—Cladribine—hematologic cancer	0.00312	0.00438	CcSEcCtD
Alvimopan—Hypokalaemia—Thalidomide—hematologic cancer	0.00308	0.00433	CcSEcCtD
Alvimopan—Malnutrition—Bexarotene—hematologic cancer	0.00307	0.00431	CcSEcCtD
Alvimopan—Malnutrition—Dasatinib—hematologic cancer	0.00307	0.00431	CcSEcCtD
Alvimopan—Malnutrition—Fludarabine—hematologic cancer	0.00306	0.0043	CcSEcCtD
Alvimopan—Urinary retention—Ifosfamide—hematologic cancer	0.00303	0.00425	CcSEcCtD
Alvimopan—Flatulence—Bexarotene—hematologic cancer	0.00302	0.00425	CcSEcCtD
Alvimopan—Anaemia—Busulfan—hematologic cancer	0.00298	0.00419	CcSEcCtD
Alvimopan—Back pain—Bexarotene—hematologic cancer	0.00297	0.00417	CcSEcCtD
Alvimopan—Hypokalaemia—Carmustine—hematologic cancer	0.00296	0.00416	CcSEcCtD
Alvimopan—Urinary retention—Vincristine—hematologic cancer	0.00295	0.00415	CcSEcCtD
Alvimopan—Hypokalaemia—Ifosfamide—hematologic cancer	0.0029	0.00407	CcSEcCtD
Alvimopan—Anaemia—Procarbazine—hematologic cancer	0.00289	0.00407	CcSEcCtD
Alvimopan—Urinary tract disorder—Melphalan—hematologic cancer	0.00287	0.00403	CcSEcCtD
Alvimopan—Connective tissue disorder—Melphalan—hematologic cancer	0.00285	0.00401	CcSEcCtD
Alvimopan—Urethral disorder—Melphalan—hematologic cancer	0.00285	0.004	CcSEcCtD
Alvimopan—Anaemia—Bexarotene—hematologic cancer	0.00284	0.00399	CcSEcCtD
Alvimopan—Anaemia—Dasatinib—hematologic cancer	0.00284	0.00399	CcSEcCtD
Alvimopan—Malnutrition—Nilotinib—hematologic cancer	0.00283	0.00398	CcSEcCtD
Alvimopan—Anaemia—Fludarabine—hematologic cancer	0.00283	0.00397	CcSEcCtD
Alvimopan—Malnutrition—Imatinib—hematologic cancer	0.00282	0.00396	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Nelarabine—hematologic cancer	0.00281	0.00394	CcSEcCtD
Alvimopan—Dyspepsia—Methoxsalen—hematologic cancer	0.0028	0.00393	CcSEcCtD
Alvimopan—Flatulence—Nilotinib—hematologic cancer	0.00279	0.00393	CcSEcCtD
Alvimopan—Urinary tract disorder—Lenalidomide—hematologic cancer	0.00279	0.00392	CcSEcCtD
Alvimopan—Constipation—Nelarabine—hematologic cancer	0.00278	0.00391	CcSEcCtD
Alvimopan—Flatulence—Imatinib—hematologic cancer	0.00278	0.0039	CcSEcCtD
Alvimopan—Connective tissue disorder—Lenalidomide—hematologic cancer	0.00277	0.0039	CcSEcCtD
Alvimopan—Malnutrition—Cladribine—hematologic cancer	0.00277	0.00389	CcSEcCtD
Alvimopan—Urethral disorder—Lenalidomide—hematologic cancer	0.00277	0.00389	CcSEcCtD
Alvimopan—Hypokalaemia—Irinotecan—hematologic cancer	0.00275	0.00387	CcSEcCtD
Alvimopan—Hypokalaemia—Mitoxantrone—hematologic cancer	0.00275	0.00387	CcSEcCtD
Alvimopan—Back pain—Nilotinib—hematologic cancer	0.00274	0.00385	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Methoxsalen—hematologic cancer	0.00274	0.00385	CcSEcCtD
Alvimopan—Flatulence—Cladribine—hematologic cancer	0.00273	0.00384	CcSEcCtD
Alvimopan—Back pain—Imatinib—hematologic cancer	0.00273	0.00383	CcSEcCtD
Alvimopan—Hypokalaemia—Gemcitabine—hematologic cancer	0.00268	0.00377	CcSEcCtD
Alvimopan—Anaemia—Chlorambucil—hematologic cancer	0.00268	0.00377	CcSEcCtD
Alvimopan—Back pain—Cladribine—hematologic cancer	0.00268	0.00377	CcSEcCtD
Alvimopan—Dyspepsia—Pentostatin—hematologic cancer	0.00267	0.00375	CcSEcCtD
Alvimopan—Dyspepsia—Anagrelide—hematologic cancer	0.00267	0.00375	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Mercaptopurine—hematologic cancer	0.00266	0.00374	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Clofarabine—hematologic cancer	0.00263	0.00369	CcSEcCtD
Alvimopan—Anaemia—Nilotinib—hematologic cancer	0.00262	0.00368	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Pentostatin—hematologic cancer	0.00261	0.00368	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Anagrelide—hematologic cancer	0.00261	0.00368	CcSEcCtD
Alvimopan—Anaemia—Imatinib—hematologic cancer	0.00261	0.00366	CcSEcCtD
Alvimopan—Constipation—Daunorubicin—hematologic cancer	0.0026	0.00366	CcSEcCtD
Alvimopan—Constipation—Anagrelide—hematologic cancer	0.00259	0.00364	CcSEcCtD
Alvimopan—Constipation—Pentostatin—hematologic cancer	0.00259	0.00364	CcSEcCtD
Alvimopan—Urinary tract disorder—Bortezomib—hematologic cancer	0.00256	0.0036	CcSEcCtD
Alvimopan—Anaemia—Cladribine—hematologic cancer	0.00256	0.0036	CcSEcCtD
Alvimopan—Connective tissue disorder—Bortezomib—hematologic cancer	0.00255	0.00359	CcSEcCtD
Alvimopan—Urethral disorder—Bortezomib—hematologic cancer	0.00255	0.00358	CcSEcCtD
Alvimopan—Hypokalaemia—Cisplatin—hematologic cancer	0.0025	0.00351	CcSEcCtD
Alvimopan—Connective tissue disorder—Vinorelbine—hematologic cancer	0.00249	0.0035	CcSEcCtD
Alvimopan—Malnutrition—Lenalidomide—hematologic cancer	0.00246	0.00345	CcSEcCtD
Alvimopan—Anaemia—Vinblastine—hematologic cancer	0.00245	0.00345	CcSEcCtD
Alvimopan—Flatulence—Lenalidomide—hematologic cancer	0.00242	0.0034	CcSEcCtD
Alvimopan—Urinary tract disorder—Thiotepa—hematologic cancer	0.00239	0.00336	CcSEcCtD
Alvimopan—Connective tissue disorder—Thiotepa—hematologic cancer	0.00238	0.00334	CcSEcCtD
Alvimopan—Back pain—Lenalidomide—hematologic cancer	0.00238	0.00334	CcSEcCtD
Alvimopan—Urethral disorder—Thiotepa—hematologic cancer	0.00237	0.00334	CcSEcCtD
Alvimopan—Anaemia—Melphalan—hematologic cancer	0.00234	0.00328	CcSEcCtD
Alvimopan—Dyspepsia—Busulfan—hematologic cancer	0.00232	0.00326	CcSEcCtD
Alvimopan—Urinary tract disorder—Thalidomide—hematologic cancer	0.00231	0.00325	CcSEcCtD
Alvimopan—Urethral disorder—Thalidomide—hematologic cancer	0.0023	0.00323	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Busulfan—hematologic cancer	0.00227	0.0032	CcSEcCtD
Alvimopan—Anaemia—Lenalidomide—hematologic cancer	0.00227	0.00319	CcSEcCtD
Alvimopan—Malnutrition—Bortezomib—hematologic cancer	0.00226	0.00318	CcSEcCtD
Alvimopan—Constipation—Busulfan—hematologic cancer	0.00225	0.00316	CcSEcCtD
Alvimopan—Anaemia—Hydroxyurea—hematologic cancer	0.00224	0.00315	CcSEcCtD
Alvimopan—Flatulence—Bortezomib—hematologic cancer	0.00223	0.00313	CcSEcCtD
Alvimopan—Connective tissue disorder—Carmustine—hematologic cancer	0.00221	0.00311	CcSEcCtD
Alvimopan—Malnutrition—Vinorelbine—hematologic cancer	0.00221	0.0031	CcSEcCtD
Alvimopan—Dyspepsia—Dasatinib—hematologic cancer	0.0022	0.0031	CcSEcCtD
Alvimopan—Dyspepsia—Bexarotene—hematologic cancer	0.0022	0.0031	CcSEcCtD
Alvimopan—Urinary tract disorder—Alitretinoin—hematologic cancer	0.0022	0.00309	CcSEcCtD
Alvimopan—Dyspepsia—Fludarabine—hematologic cancer	0.0022	0.00309	CcSEcCtD
Alvimopan—Back pain—Bortezomib—hematologic cancer	0.00219	0.00307	CcSEcCtD
Alvimopan—Urethral disorder—Alitretinoin—hematologic cancer	0.00218	0.00307	CcSEcCtD
Alvimopan—Constipation—Procarbazine—hematologic cancer	0.00218	0.00307	CcSEcCtD
Alvimopan—Urinary tract disorder—Ifosfamide—hematologic cancer	0.00218	0.00306	CcSEcCtD
Alvimopan—Connective tissue disorder—Ifosfamide—hematologic cancer	0.00216	0.00304	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Bexarotene—hematologic cancer	0.00216	0.00304	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Dasatinib—hematologic cancer	0.00216	0.00304	CcSEcCtD
Alvimopan—Urethral disorder—Ifosfamide—hematologic cancer	0.00216	0.00303	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Fludarabine—hematologic cancer	0.00216	0.00303	CcSEcCtD
Alvimopan—Constipation—Bexarotene—hematologic cancer	0.00214	0.00301	CcSEcCtD
Alvimopan—Constipation—Dasatinib—hematologic cancer	0.00214	0.00301	CcSEcCtD
Alvimopan—Constipation—Fludarabine—hematologic cancer	0.00214	0.003	CcSEcCtD
Alvimopan—Back pain—Vinorelbine—hematologic cancer	0.00214	0.003	CcSEcCtD
Alvimopan—Urinary tract disorder—Vincristine—hematologic cancer	0.00212	0.00298	CcSEcCtD
Alvimopan—Connective tissue disorder—Vincristine—hematologic cancer	0.00211	0.00297	CcSEcCtD
Alvimopan—Malnutrition—Thiotepa—hematologic cancer	0.00211	0.00296	CcSEcCtD
Alvimopan—Urethral disorder—Vincristine—hematologic cancer	0.0021	0.00296	CcSEcCtD
Alvimopan—Anaemia—Bortezomib—hematologic cancer	0.00209	0.00294	CcSEcCtD
Alvimopan—Dyspepsia—Chlorambucil—hematologic cancer	0.00208	0.00293	CcSEcCtD
Alvimopan—Anaemia—Bleomycin—hematologic cancer	0.00207	0.00291	CcSEcCtD
Alvimopan—Connective tissue disorder—Irinotecan—hematologic cancer	0.00206	0.00289	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Chlorambucil—hematologic cancer	0.00204	0.00287	CcSEcCtD
Alvimopan—Anaemia—Vinorelbine—hematologic cancer	0.00204	0.00287	CcSEcCtD
Alvimopan—Back pain—Thiotepa—hematologic cancer	0.00204	0.00287	CcSEcCtD
Alvimopan—Malnutrition—Thalidomide—hematologic cancer	0.00204	0.00287	CcSEcCtD
Alvimopan—Dyspepsia—Nilotinib—hematologic cancer	0.00204	0.00286	CcSEcCtD
Alvimopan—Dyspepsia—Imatinib—hematologic cancer	0.00202	0.00285	CcSEcCtD
Alvimopan—Urinary tract disorder—Gemcitabine—hematologic cancer	0.00201	0.00283	CcSEcCtD
Alvimopan—Flatulence—Thalidomide—hematologic cancer	0.00201	0.00282	CcSEcCtD
Alvimopan—Connective tissue disorder—Gemcitabine—hematologic cancer	0.002	0.00281	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Nilotinib—hematologic cancer	0.002	0.00281	CcSEcCtD
Alvimopan—Urethral disorder—Gemcitabine—hematologic cancer	0.002	0.00281	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Imatinib—hematologic cancer	0.00199	0.00279	CcSEcCtD
Alvimopan—Constipation—Nilotinib—hematologic cancer	0.00198	0.00278	CcSEcCtD
Alvimopan—Back pain—Thalidomide—hematologic cancer	0.00197	0.00277	CcSEcCtD
Alvimopan—Constipation—Imatinib—hematologic cancer	0.00197	0.00277	CcSEcCtD
Alvimopan—Malnutrition—Carmustine—hematologic cancer	0.00196	0.00275	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Cladribine—hematologic cancer	0.00195	0.00274	CcSEcCtD
Alvimopan—Anaemia—Thiotepa—hematologic cancer	0.00195	0.00274	CcSEcCtD
Alvimopan—Malnutrition—Alitretinoin—hematologic cancer	0.00194	0.00273	CcSEcCtD
Alvimopan—Constipation—Cladribine—hematologic cancer	0.00193	0.00272	CcSEcCtD
Alvimopan—Malnutrition—Ifosfamide—hematologic cancer	0.00192	0.00269	CcSEcCtD
Alvimopan—Flatulence—Alitretinoin—hematologic cancer	0.00191	0.00269	CcSEcCtD
Alvimopan—Back pain—Carmustine—hematologic cancer	0.00189	0.00266	CcSEcCtD
Alvimopan—Anaemia—Thalidomide—hematologic cancer	0.00188	0.00265	CcSEcCtD
Alvimopan—Hypokalaemia—Betamethasone—hematologic cancer	0.00188	0.00265	CcSEcCtD
Alvimopan—Hypokalaemia—Dexamethasone—hematologic cancer	0.00188	0.00265	CcSEcCtD
Alvimopan—Back pain—Alitretinoin—hematologic cancer	0.00188	0.00264	CcSEcCtD
Alvimopan—Urinary tract disorder—Cisplatin—hematologic cancer	0.00188	0.00264	CcSEcCtD
Alvimopan—Connective tissue disorder—Cisplatin—hematologic cancer	0.00187	0.00262	CcSEcCtD
Alvimopan—Urethral disorder—Cisplatin—hematologic cancer	0.00186	0.00262	CcSEcCtD
Alvimopan—Constipation—Vinblastine—hematologic cancer	0.00185	0.00261	CcSEcCtD
Alvimopan—Dyspepsia—Melphalan—hematologic cancer	0.00182	0.00255	CcSEcCtD
Alvimopan—Anaemia—Carmustine—hematologic cancer	0.00181	0.00254	CcSEcCtD
Alvimopan—Back pain—Vincristine—hematologic cancer	0.00181	0.00254	CcSEcCtD
Alvimopan—Flatulence—Irinotecan—hematologic cancer	0.00179	0.00252	CcSEcCtD
Alvimopan—Anaemia—Alitretinoin—hematologic cancer	0.00179	0.00252	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Melphalan—hematologic cancer	0.00178	0.0025	CcSEcCtD
Alvimopan—Anaemia—Ifosfamide—hematologic cancer	0.00177	0.00249	CcSEcCtD
Alvimopan—Dyspepsia—Lenalidomide—hematologic cancer	0.00176	0.00248	CcSEcCtD
Alvimopan—Back pain—Mitoxantrone—hematologic cancer	0.00176	0.00248	CcSEcCtD
Alvimopan—Back pain—Irinotecan—hematologic cancer	0.00176	0.00248	CcSEcCtD
Alvimopan—Dyspepsia—Hydroxyurea—hematologic cancer	0.00174	0.00245	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Lenalidomide—hematologic cancer	0.00173	0.00243	CcSEcCtD
Alvimopan—Anaemia—Vincristine—hematologic cancer	0.00173	0.00243	CcSEcCtD
Alvimopan—Urinary tract disorder—Etoposide—hematologic cancer	0.00172	0.00241	CcSEcCtD
Alvimopan—Back pain—Gemcitabine—hematologic cancer	0.00172	0.00241	CcSEcCtD
Alvimopan—Constipation—Lenalidomide—hematologic cancer	0.00171	0.00241	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Hydroxyurea—hematologic cancer	0.00171	0.0024	CcSEcCtD
Alvimopan—Urethral disorder—Etoposide—hematologic cancer	0.00171	0.0024	CcSEcCtD
Alvimopan—Constipation—Hydroxyurea—hematologic cancer	0.00169	0.00238	CcSEcCtD
Alvimopan—Anaemia—Irinotecan—hematologic cancer	0.00168	0.00236	CcSEcCtD
Alvimopan—Anaemia—Mitoxantrone—hematologic cancer	0.00168	0.00236	CcSEcCtD
Alvimopan—Malnutrition—Cisplatin—hematologic cancer	0.00165	0.00232	CcSEcCtD
Alvimopan—Hypokalaemia—Prednisone—hematologic cancer	0.00164	0.00231	CcSEcCtD
Alvimopan—Anaemia—Gemcitabine—hematologic cancer	0.00164	0.0023	CcSEcCtD
Alvimopan—Flatulence—Cisplatin—hematologic cancer	0.00163	0.00229	CcSEcCtD
Alvimopan—Dyspepsia—Bortezomib—hematologic cancer	0.00162	0.00228	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Bortezomib—hematologic cancer	0.00159	0.00224	CcSEcCtD
Alvimopan—Constipation—Bortezomib—hematologic cancer	0.00158	0.00222	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Vinorelbine—hematologic cancer	0.00156	0.00219	CcSEcCtD
Alvimopan—Constipation—Vinorelbine—hematologic cancer	0.00154	0.00217	CcSEcCtD
Alvimopan—Anaemia—Cisplatin—hematologic cancer	0.00153	0.00215	CcSEcCtD
Alvimopan—Dyspepsia—Thiotepa—hematologic cancer	0.00151	0.00213	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Thiotepa—hematologic cancer	0.00149	0.00209	CcSEcCtD
Alvimopan—Constipation—Thiotepa—hematologic cancer	0.00147	0.00207	CcSEcCtD
Alvimopan—Dyspepsia—Thalidomide—hematologic cancer	0.00146	0.00206	CcSEcCtD
Alvimopan—Back pain—Etoposide—hematologic cancer	0.00146	0.00206	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Thalidomide—hematologic cancer	0.00144	0.00202	CcSEcCtD
Alvimopan—Constipation—Thalidomide—hematologic cancer	0.00142	0.002	CcSEcCtD
Alvimopan—Anaemia—Etoposide—hematologic cancer	0.0014	0.00197	CcSEcCtD
Alvimopan—Dyspepsia—Alitretinoin—hematologic cancer	0.00139	0.00196	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Carmustine—hematologic cancer	0.00138	0.00194	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Alitretinoin—hematologic cancer	0.00137	0.00192	CcSEcCtD
Alvimopan—Constipation—Carmustine—hematologic cancer	0.00137	0.00192	CcSEcCtD
Alvimopan—Indinavir—ABCB1—hematologic cancer	0.00136	0.129	CrCbGaD
Alvimopan—Constipation—Alitretinoin—hematologic cancer	0.00135	0.0019	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Ifosfamide—hematologic cancer	0.00135	0.0019	CcSEcCtD
Alvimopan—Constipation—Ifosfamide—hematologic cancer	0.00134	0.00188	CcSEcCtD
Alvimopan—Back pain—Triamcinolone—hematologic cancer	0.00133	0.00187	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Vincristine—hematologic cancer	0.00132	0.00185	CcSEcCtD
Alvimopan—Dyspepsia—Irinotecan—hematologic cancer	0.00131	0.00184	CcSEcCtD
Alvimopan—Dyspepsia—Mitoxantrone—hematologic cancer	0.00131	0.00184	CcSEcCtD
Alvimopan—Constipation—Vincristine—hematologic cancer	0.0013	0.00183	CcSEcCtD
Alvimopan—Hypokalaemia—Epirubicin—hematologic cancer	0.00128	0.0018	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Irinotecan—hematologic cancer	0.00128	0.0018	CcSEcCtD
Alvimopan—Constipation—Irinotecan—hematologic cancer	0.00127	0.00179	CcSEcCtD
Alvimopan—Constipation—Mitoxantrone—hematologic cancer	0.00127	0.00179	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Gemcitabine—hematologic cancer	0.00125	0.00176	CcSEcCtD
Alvimopan—Constipation—Gemcitabine—hematologic cancer	0.00124	0.00174	CcSEcCtD
Alvimopan—Connective tissue disorder—Prednisone—hematologic cancer	0.00123	0.00172	CcSEcCtD
Alvimopan—Hypokalaemia—Doxorubicin—hematologic cancer	0.00119	0.00167	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Cisplatin—hematologic cancer	0.00116	0.00164	CcSEcCtD
Alvimopan—Malnutrition—Prednisone—hematologic cancer	0.00109	0.00153	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Etoposide—hematologic cancer	0.00107	0.0015	CcSEcCtD
Alvimopan—Constipation—Etoposide—hematologic cancer	0.00106	0.00149	CcSEcCtD
Alvimopan—Urinary tract disorder—Methotrexate—hematologic cancer	0.00103	0.00145	CcSEcCtD
Alvimopan—Urethral disorder—Methotrexate—hematologic cancer	0.00102	0.00144	CcSEcCtD
Alvimopan—Anaemia—Prednisone—hematologic cancer	0.001	0.00141	CcSEcCtD
Alvimopan—Dyspepsia—Triamcinolone—hematologic cancer	0.000987	0.00139	CcSEcCtD
Alvimopan—Urinary tract disorder—Epirubicin—hematologic cancer	0.000963	0.00135	CcSEcCtD
Alvimopan—Connective tissue disorder—Epirubicin—hematologic cancer	0.000958	0.00135	CcSEcCtD
Alvimopan—Urethral disorder—Epirubicin—hematologic cancer	0.000956	0.00134	CcSEcCtD
Alvimopan—Malnutrition—Methotrexate—hematologic cancer	0.000907	0.00127	CcSEcCtD
Alvimopan—Dyspepsia—Betamethasone—hematologic cancer	0.000895	0.00126	CcSEcCtD
Alvimopan—Dyspepsia—Dexamethasone—hematologic cancer	0.000895	0.00126	CcSEcCtD
Alvimopan—Urinary tract disorder—Doxorubicin—hematologic cancer	0.000891	0.00125	CcSEcCtD
Alvimopan—Connective tissue disorder—Doxorubicin—hematologic cancer	0.000887	0.00125	CcSEcCtD
Alvimopan—Urethral disorder—Doxorubicin—hematologic cancer	0.000884	0.00124	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Betamethasone—hematologic cancer	0.000878	0.00123	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Dexamethasone—hematologic cancer	0.000878	0.00123	CcSEcCtD
Alvimopan—Back pain—Methotrexate—hematologic cancer	0.000877	0.00123	CcSEcCtD
Alvimopan—Malnutrition—Epirubicin—hematologic cancer	0.000849	0.00119	CcSEcCtD
Alvimopan—Anaemia—Methotrexate—hematologic cancer	0.000838	0.00118	CcSEcCtD
Alvimopan—Flatulence—Epirubicin—hematologic cancer	0.000836	0.00118	CcSEcCtD
Alvimopan—Back pain—Epirubicin—hematologic cancer	0.000821	0.00115	CcSEcCtD
Alvimopan—Malnutrition—Doxorubicin—hematologic cancer	0.000785	0.0011	CcSEcCtD
Alvimopan—Anaemia—Epirubicin—hematologic cancer	0.000785	0.0011	CcSEcCtD
Alvimopan—Dyspepsia—Prednisone—hematologic cancer	0.00078	0.0011	CcSEcCtD
Alvimopan—Flatulence—Doxorubicin—hematologic cancer	0.000774	0.00109	CcSEcCtD
Alvimopan—Back pain—Doxorubicin—hematologic cancer	0.00076	0.00107	CcSEcCtD
Alvimopan—Constipation—Prednisone—hematologic cancer	0.000757	0.00106	CcSEcCtD
Alvimopan—Anaemia—Doxorubicin—hematologic cancer	0.000726	0.00102	CcSEcCtD
Alvimopan—Ketoprofen—ALB—hematologic cancer	0.000682	0.0649	CrCbGaD
Alvimopan—Dyspepsia—Methotrexate—hematologic cancer	0.000652	0.000916	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Methotrexate—hematologic cancer	0.000639	0.000898	CcSEcCtD
Alvimopan—Dyspepsia—Epirubicin—hematologic cancer	0.00061	0.000857	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Epirubicin—hematologic cancer	0.000598	0.000841	CcSEcCtD
Alvimopan—Constipation—Epirubicin—hematologic cancer	0.000592	0.000833	CcSEcCtD
Alvimopan—Dyspepsia—Doxorubicin—hematologic cancer	0.000564	0.000793	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Doxorubicin—hematologic cancer	0.000553	0.000778	CcSEcCtD
Alvimopan—Constipation—Doxorubicin—hematologic cancer	0.000548	0.00077	CcSEcCtD
Alvimopan—OPRD1—Signaling Pathways—FGF1—hematologic cancer	8.09e-05	0.000291	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—JAK2—hematologic cancer	8.01e-05	0.000288	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CXCR4—hematologic cancer	8e-05	0.000288	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—HDAC2—hematologic cancer	8e-05	0.000288	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—MAP2K1—hematologic cancer	7.98e-05	0.000287	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—FOXO1—hematologic cancer	7.97e-05	0.000287	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—IL2—hematologic cancer	7.97e-05	0.000287	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—PDGFRB—hematologic cancer	7.96e-05	0.000286	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—GRB2—hematologic cancer	7.94e-05	0.000285	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—PIK3CD—hematologic cancer	7.93e-05	0.000285	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—PDGFA—hematologic cancer	7.92e-05	0.000285	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—PIK3CB—hematologic cancer	7.88e-05	0.000283	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—PDGFRA—hematologic cancer	7.83e-05	0.000282	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—JAK1—hematologic cancer	7.81e-05	0.000281	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—PRKCG—hematologic cancer	7.81e-05	0.000281	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—KITLG—hematologic cancer	7.81e-05	0.000281	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CBL—hematologic cancer	7.79e-05	0.00028	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—IL3—hematologic cancer	7.71e-05	0.000277	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—STAT5A—hematologic cancer	7.63e-05	0.000274	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—PIK3CG—hematologic cancer	7.62e-05	0.000274	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—PIK3CB—hematologic cancer	7.61e-05	0.000274	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—PTPN1—hematologic cancer	7.58e-05	0.000273	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CDKN2B—hematologic cancer	7.56e-05	0.000272	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—PTPN11—hematologic cancer	7.49e-05	0.000269	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—PIK3R1—hematologic cancer	7.48e-05	0.000269	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—RASGRP1—hematologic cancer	7.46e-05	0.000268	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—HSP90AA1—hematologic cancer	7.44e-05	0.000267	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—SYK—hematologic cancer	7.44e-05	0.000267	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—PIK3CD—hematologic cancer	7.38e-05	0.000265	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CD86—hematologic cancer	7.31e-05	0.000263	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—IL2RA—hematologic cancer	7.29e-05	0.000262	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—JAK2—hematologic cancer	7.27e-05	0.000262	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—CREB1—hematologic cancer	7.25e-05	0.000261	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—IL2—hematologic cancer	7.24e-05	0.00026	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—HES1—hematologic cancer	7.21e-05	0.000259	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—TERT—hematologic cancer	7.21e-05	0.000259	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—NCOR1—hematologic cancer	7.17e-05	0.000258	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—STAT1—hematologic cancer	7.17e-05	0.000258	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—CCL2—hematologic cancer	7.1e-05	0.000255	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—FGF1—hematologic cancer	7.09e-05	0.000255	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CSF2—hematologic cancer	7.09e-05	0.000255	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—IL6R—hematologic cancer	7.08e-05	0.000254	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—PDGFB—hematologic cancer	7.04e-05	0.000253	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—FOXO1—hematologic cancer	6.99e-05	0.000251	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—IL2—hematologic cancer	6.99e-05	0.000251	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—PDGFRB—hematologic cancer	6.98e-05	0.000251	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—PIK3R1—hematologic cancer	6.97e-05	0.000251	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—PIK3CB—hematologic cancer	6.91e-05	0.000248	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—TSC2—hematologic cancer	6.88e-05	0.000247	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—PDGFRA—hematologic cancer	6.87e-05	0.000247	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—PRKCG—hematologic cancer	6.85e-05	0.000246	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—JAK1—hematologic cancer	6.85e-05	0.000246	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—JAK2—hematologic cancer	6.77e-05	0.000243	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—MAP2K1—hematologic cancer	6.74e-05	0.000243	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—GRB2—hematologic cancer	6.71e-05	0.000241	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—PIK3CD—hematologic cancer	6.7e-05	0.000241	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—PDGFA—hematologic cancer	6.69e-05	0.000241	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—FGFR3—hematologic cancer	6.62e-05	0.000238	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—KITLG—hematologic cancer	6.6e-05	0.000237	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—MAPK14—hematologic cancer	6.55e-05	0.000236	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—STAT5A—hematologic cancer	6.45e-05	0.000232	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—PIK3CB—hematologic cancer	6.43e-05	0.000231	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—ESR1—hematologic cancer	6.43e-05	0.000231	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—IL2RA—hematologic cancer	6.39e-05	0.00023	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CDKN2B—hematologic cancer	6.39e-05	0.00023	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—FN1—hematologic cancer	6.35e-05	0.000228	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—IL2—hematologic cancer	6.34e-05	0.000228	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—PIK3R1—hematologic cancer	6.33e-05	0.000228	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—TERT—hematologic cancer	6.32e-05	0.000227	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—NFKBIA—hematologic cancer	6.27e-05	0.000226	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—BAD—hematologic cancer	6.27e-05	0.000226	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—NOTCH1—hematologic cancer	6.21e-05	0.000223	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CD86—hematologic cancer	6.18e-05	0.000222	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—PDGFB—hematologic cancer	6.17e-05	0.000222	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—JAK2—hematologic cancer	6.15e-05	0.000221	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—HES1—hematologic cancer	6.1e-05	0.000219	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CD80—hematologic cancer	6.08e-05	0.000219	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—PIK3CG—hematologic cancer	6.07e-05	0.000218	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—KIT—hematologic cancer	6.07e-05	0.000218	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—NRAS—hematologic cancer	6.07e-05	0.000218	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—NCOR1—hematologic cancer	6.06e-05	0.000218	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—TSC2—hematologic cancer	6.03e-05	0.000217	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—FGF1—hematologic cancer	5.99e-05	0.000216	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CSF2—hematologic cancer	5.99e-05	0.000216	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—PTPN11—hematologic cancer	5.97e-05	0.000215	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—FOXO1—hematologic cancer	5.91e-05	0.000212	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—IL2—hematologic cancer	5.9e-05	0.000212	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—PDGFRB—hematologic cancer	5.9e-05	0.000212	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—PIK3CB—hematologic cancer	5.84e-05	0.00021	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—MAPK3—hematologic cancer	5.82e-05	0.000209	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—PDGFRA—hematologic cancer	5.81e-05	0.000209	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—FGFR3—hematologic cancer	5.8e-05	0.000209	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—JAK1—hematologic cancer	5.79e-05	0.000208	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—PRKCG—hematologic cancer	5.79e-05	0.000208	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CREB1—hematologic cancer	5.78e-05	0.000208	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—MAPK14—hematologic cancer	5.74e-05	0.000207	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—BRAF—hematologic cancer	5.71e-05	0.000205	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CCL2—hematologic cancer	5.66e-05	0.000203	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—IL6R—hematologic cancer	5.64e-05	0.000203	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—ESR1—hematologic cancer	5.63e-05	0.000203	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CREBBP—hematologic cancer	5.63e-05	0.000203	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—FN1—hematologic cancer	5.57e-05	0.0002	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—BAD—hematologic cancer	5.5e-05	0.000198	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—NFKBIA—hematologic cancer	5.5e-05	0.000198	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—NOTCH1—hematologic cancer	5.45e-05	0.000196	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—IL2RA—hematologic cancer	5.4e-05	0.000194	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—MAP2K1—hematologic cancer	5.37e-05	0.000193	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—IL2—hematologic cancer	5.36e-05	0.000193	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—TERT—hematologic cancer	5.34e-05	0.000192	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—PIK3CD—hematologic cancer	5.34e-05	0.000192	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CD80—hematologic cancer	5.34e-05	0.000192	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—KIT—hematologic cancer	5.33e-05	0.000192	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—PIK3CG—hematologic cancer	5.33e-05	0.000192	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—NRAS—hematologic cancer	5.33e-05	0.000192	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—PIK3CA—hematologic cancer	5.29e-05	0.00019	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—PTPN11—hematologic cancer	5.23e-05	0.000188	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—KRAS—hematologic cancer	5.23e-05	0.000188	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—PDGFB—hematologic cancer	5.21e-05	0.000188	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—FGF2—hematologic cancer	5.11e-05	0.000184	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—MAPK3—hematologic cancer	5.1e-05	0.000183	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—TSC2—hematologic cancer	5.1e-05	0.000183	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CREB1—hematologic cancer	5.07e-05	0.000182	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—PIK3R1—hematologic cancer	5.04e-05	0.000181	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—BRAF—hematologic cancer	5.01e-05	0.00018	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CCL2—hematologic cancer	4.96e-05	0.000178	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—IL6R—hematologic cancer	4.95e-05	0.000178	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CREBBP—hematologic cancer	4.94e-05	0.000178	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—FGFR3—hematologic cancer	4.9e-05	0.000176	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—JAK2—hematologic cancer	4.9e-05	0.000176	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—MAPK14—hematologic cancer	4.85e-05	0.000175	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—PIK3CA—hematologic cancer	4.8e-05	0.000173	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—MDM2—hematologic cancer	4.78e-05	0.000172	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—ESR1—hematologic cancer	4.76e-05	0.000171	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—MAP2K1—hematologic cancer	4.71e-05	0.00017	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—FN1—hematologic cancer	4.7e-05	0.000169	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—PIK3CD—hematologic cancer	4.68e-05	0.000168	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—MTOR—hematologic cancer	4.65e-05	0.000167	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—PIK3CB—hematologic cancer	4.65e-05	0.000167	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—BAD—hematologic cancer	4.65e-05	0.000167	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—NFKBIA—hematologic cancer	4.65e-05	0.000167	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—PIK3CA—hematologic cancer	4.64e-05	0.000167	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—NOTCH1—hematologic cancer	4.6e-05	0.000166	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—KRAS—hematologic cancer	4.58e-05	0.000165	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CD80—hematologic cancer	4.51e-05	0.000162	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—PIK3CG—hematologic cancer	4.5e-05	0.000162	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—KIT—hematologic cancer	4.5e-05	0.000162	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—NRAS—hematologic cancer	4.5e-05	0.000162	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—FGF2—hematologic cancer	4.48e-05	0.000161	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—HRAS—hematologic cancer	4.44e-05	0.00016	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—PTPN11—hematologic cancer	4.42e-05	0.000159	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—PIK3R1—hematologic cancer	4.42e-05	0.000159	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CDKN1B—hematologic cancer	4.37e-05	0.000157	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—AKT1—hematologic cancer	4.32e-05	0.000155	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—MAPK3—hematologic cancer	4.31e-05	0.000155	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—JAK2—hematologic cancer	4.3e-05	0.000155	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CREB1—hematologic cancer	4.28e-05	0.000154	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CASP3—hematologic cancer	4.28e-05	0.000154	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—IL2—hematologic cancer	4.27e-05	0.000154	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—IL6—hematologic cancer	4.25e-05	0.000153	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—BRAF—hematologic cancer	4.23e-05	0.000152	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—PIK3CA—hematologic cancer	4.21e-05	0.000151	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—MDM2—hematologic cancer	4.19e-05	0.000151	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CCL2—hematologic cancer	4.19e-05	0.000151	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—IL6R—hematologic cancer	4.18e-05	0.00015	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CREBBP—hematologic cancer	4.17e-05	0.00015	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CCND1—hematologic cancer	4.17e-05	0.00015	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—JUN—hematologic cancer	4.16e-05	0.00015	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—MTOR—hematologic cancer	4.08e-05	0.000147	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—PIK3CB—hematologic cancer	4.08e-05	0.000147	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CDKN1A—hematologic cancer	4.03e-05	0.000145	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—PTEN—hematologic cancer	4.02e-05	0.000145	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—MAP2K1—hematologic cancer	3.98e-05	0.000143	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—PIK3CD—hematologic cancer	3.96e-05	0.000142	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—MAPK8—hematologic cancer	3.93e-05	0.000142	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—AKT1—hematologic cancer	3.92e-05	0.000141	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—PIK3CA—hematologic cancer	3.92e-05	0.000141	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—HRAS—hematologic cancer	3.9e-05	0.00014	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—KRAS—hematologic cancer	3.87e-05	0.000139	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—EP300—hematologic cancer	3.84e-05	0.000138	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CDKN1B—hematologic cancer	3.83e-05	0.000138	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—FGF2—hematologic cancer	3.79e-05	0.000136	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—AKT1—hematologic cancer	3.79e-05	0.000136	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CASP3—hematologic cancer	3.75e-05	0.000135	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—IL2—hematologic cancer	3.75e-05	0.000135	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—PIK3R1—hematologic cancer	3.74e-05	0.000134	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—SRC—hematologic cancer	3.73e-05	0.000134	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—IL6—hematologic cancer	3.73e-05	0.000134	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CCND1—hematologic cancer	3.65e-05	0.000131	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—JUN—hematologic cancer	3.65e-05	0.000131	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—VEGFA—hematologic cancer	3.63e-05	0.000131	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—JAK2—hematologic cancer	3.63e-05	0.000131	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—STAT3—hematologic cancer	3.6e-05	0.000129	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—NRAS—hematologic cancer	3.59e-05	0.000129	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—PIK3CA—hematologic cancer	3.56e-05	0.000128	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—MDM2—hematologic cancer	3.54e-05	0.000128	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CDKN1A—hematologic cancer	3.53e-05	0.000127	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—PTEN—hematologic cancer	3.53e-05	0.000127	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—MAPK8—hematologic cancer	3.45e-05	0.000124	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—MTOR—hematologic cancer	3.45e-05	0.000124	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—PIK3CB—hematologic cancer	3.45e-05	0.000124	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—AKT1—hematologic cancer	3.44e-05	0.000124	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—MAPK3—hematologic cancer	3.44e-05	0.000124	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—EP300—hematologic cancer	3.36e-05	0.000121	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—MYC—hematologic cancer	3.34e-05	0.00012	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—TGFB1—hematologic cancer	3.33e-05	0.00012	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—HRAS—hematologic cancer	3.29e-05	0.000118	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—SRC—hematologic cancer	3.27e-05	0.000118	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CDKN1B—hematologic cancer	3.24e-05	0.000116	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—AKT1—hematologic cancer	3.2e-05	0.000115	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—VEGFA—hematologic cancer	3.19e-05	0.000115	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CASP3—hematologic cancer	3.17e-05	0.000114	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—IL2—hematologic cancer	3.17e-05	0.000114	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—STAT3—hematologic cancer	3.15e-05	0.000113	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—IL6—hematologic cancer	3.15e-05	0.000113	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—NRAS—hematologic cancer	3.15e-05	0.000113	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—KRAS—hematologic cancer	3.09e-05	0.000111	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CCND1—hematologic cancer	3.09e-05	0.000111	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—JUN—hematologic cancer	3.08e-05	0.000111	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—MAPK3—hematologic cancer	3.01e-05	0.000108	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CDKN1A—hematologic cancer	2.99e-05	0.000107	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—PTEN—hematologic cancer	2.98e-05	0.000107	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—MYC—hematologic cancer	2.93e-05	0.000105	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—TGFB1—hematologic cancer	2.92e-05	0.000105	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—MAPK8—hematologic cancer	2.92e-05	0.000105	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—AKT1—hematologic cancer	2.91e-05	0.000105	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—EP300—hematologic cancer	2.84e-05	0.000102	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—PIK3CA—hematologic cancer	2.84e-05	0.000102	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—SRC—hematologic cancer	2.76e-05	9.94e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—TP53—hematologic cancer	2.74e-05	9.87e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—KRAS—hematologic cancer	2.71e-05	9.74e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—VEGFA—hematologic cancer	2.69e-05	9.68e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—STAT3—hematologic cancer	2.67e-05	9.59e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—NRAS—hematologic cancer	2.66e-05	9.56e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—HRAS—hematologic cancer	2.62e-05	9.44e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—MAPK3—hematologic cancer	2.55e-05	9.16e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—IL6—hematologic cancer	2.51e-05	9.04e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—PIK3CA—hematologic cancer	2.49e-05	8.95e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—MYC—hematologic cancer	2.48e-05	8.91e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—TGFB1—hematologic cancer	2.47e-05	8.89e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—TP53—hematologic cancer	2.41e-05	8.66e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—AKT1—hematologic cancer	2.32e-05	8.34e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—HRAS—hematologic cancer	2.3e-05	8.28e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—KRAS—hematologic cancer	2.29e-05	8.23e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—IL6—hematologic cancer	2.2e-05	7.92e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—PIK3CA—hematologic cancer	2.1e-05	7.56e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—TP53—hematologic cancer	2.03e-05	7.32e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—AKT1—hematologic cancer	2.03e-05	7.31e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—HRAS—hematologic cancer	1.95e-05	7e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—IL6—hematologic cancer	1.86e-05	6.7e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—AKT1—hematologic cancer	1.72e-05	6.18e-05	CbGpPWpGaD
